|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-8-12
|
|
pubmed:abstractText |
Fluorescence in situ hybridization is gaining popularity for transitional cell carcinoma screening. We determined the accuracy of fluorescence in situ hybridization for identifying upper tract transitional cell carcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-3792
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
184
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
879-82
|
|
pubmed:meshHeading |
pubmed-meshheading:20643443-Aged,
pubmed-meshheading:20643443-Carcinoma, Transitional Cell,
pubmed-meshheading:20643443-Female,
pubmed-meshheading:20643443-Humans,
pubmed-meshheading:20643443-In Situ Hybridization, Fluorescence,
pubmed-meshheading:20643443-Kidney Neoplasms,
pubmed-meshheading:20643443-Kidney Pelvis,
pubmed-meshheading:20643443-Male,
pubmed-meshheading:20643443-Neoplasms, Multiple Primary,
pubmed-meshheading:20643443-Population Surveillance,
pubmed-meshheading:20643443-Reproducibility of Results,
pubmed-meshheading:20643443-Retrospective Studies,
pubmed-meshheading:20643443-Ureteral Neoplasms,
pubmed-meshheading:20643443-Urinary Bladder Neoplasms
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance.
|
|
pubmed:affiliation |
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article
|
